Entasis Therapeutics to Participate in Upcoming Healthcare Investor Conferences
WALTHAM, Mass., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced that Dr. Manos Perros, President and Chief Executive Officer of the Company, will present virtually at the H.C. Wainwright & Co. 22nd Annual Global Investment Conference on September 15th, the Cantor 2020 Virtual Global Healthcare Conference on September 17th, and the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22nd.
A replay of the Cantor presentation will be available on the Company’s website for 90 days following the event. Additionally, Dr. Perros will hold 1-on-1 virtual investor meetings a the conferences. Investors attending the conferences virtually who are interested in meeting with Company management should contact their H.C Wainwright, Cantor, and Oppenheimer representatives.
Entasis Forward-looking Statements
Entasis Company Contact
Investor Relations Contacts